<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url><loc>https://www.philogen.com/</loc></url>
<url><loc>https://www.philogen.com/innovation/</loc></url>
<url><loc>https://www.philogen.com/pipeline/</loc></url>
<url><loc>https://www.philogen.com/services/</loc></url>
<url><loc>https://www.philogen.com/news-media/</loc></url>
<url><loc>https://www.philogen.com/about/</loc></url>
<url><loc>https://www.philogen.com/about/board-of-directors/</loc></url>
<url><loc>https://www.philogen.com/about/board-of-statutory-auditors/</loc></url>
<url><loc>https://www.philogen.com/about/scientific-advisory-board/</loc></url>
<url><loc>https://www.philogen.com/governance/</loc></url>
<url><loc>https://www.philogen.com/investors/</loc></url>
<url><loc>https://www.philogen.com/publications/</loc></url>
<url><loc>https://www.philogen.com/innovation/references/</loc></url>
<url><loc>https://www.philogen.com/careers/</loc></url>
<url><loc>https://www.philogen.com/contact/</loc></url>
<url><loc>https://www.philogen.com/documents/</loc></url>
<url><loc>https://www.philogen.com/investors/ir-contacts/</loc></url>
<url><loc>https://www.philogen.com/press-releases-events/press-releases/</loc></url>
<url><loc>https://www.philogen.com/press-releases-events/events/</loc></url>
<url><loc>https://www.philogen.com/press-releases-events/media-library/</loc></url>
<url><loc>https://www.philogen.com/privacy-policy/</loc></url>
<url><loc>https://www.philogen.com/cookie-policy/</loc></url>
<url><loc>https://www.philogen.com/investors/financial-statements/</loc></url>
<url><loc>https://www.philogen.com/investors/financial-calendar/</loc></url>
<url><loc>https://www.philogen.com/investors/internal-dealing/</loc></url>
<url><loc>https://www.philogen.com/investors/buyback/</loc></url>
<url><loc>https://www.philogen.com/investors/press-releases/</loc></url>
<url><loc>https://www.philogen.com/governance/shareholders-meeting/</loc></url>
<url><loc>https://www.philogen.com/governance/by-laws-statuto/</loc></url>
<url><loc>https://www.philogen.com/governance/codice-etico-e-modello-231/</loc></url>
<url><loc>https://www.philogen.com/governance/documents-procedures/</loc></url>
<url><loc>https://www.philogen.com/governance/incentive-plans/</loc></url>
<url><loc>https://www.philogen.com/governance/sustainability-esg/</loc></url>
<url><loc>https://www.philogen.com/press-releases-events/philogen-in-the-news/</loc></url>
<url><loc>https://www.philogen.com/project-funded-by-por-creo-2014-2020/</loc></url>
<url><loc>https://www.philogen.com/investors/shareholding/</loc></url>
<url><loc>https://www.philogen.com/investors/ipo/</loc></url>
<url><loc>https://www.philogen.com/investors/analyst-coverage/</loc></url>
<url><loc>https://www.philogen.com/investors/webinars/</loc></url>
<url><loc>https://www.philogen.com/investors/investor-relations/</loc></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-an-upcoming-webinar-on-september-25-2026-at-1400-gmt-1500-cet/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2026-price-sensitive/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2026-price-sensitive-courtesy-english-translation/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://www.philogen.com/news/updated-phase-iii-pivotal-results-for-nidlegy-published-in-the-journal-of-clinical-oncology/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://www.philogen.com/news/nidlegy-marketing-authorization-application-resubmitted-to-ema/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti-5/</loc><lastmod>2026-05-21</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2026/</loc><lastmod>2026-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-financial-position-for-the-first-quarter-of-2026-courtesy-english-translation/</loc><lastmod>2026-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-society-of-nuclear-medicine-and-molecular-imaging-snmm-annual-meeting-on-may-30-june-2-2026/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-festival-of-biologics-13-15-october-2026/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-summer-school-in-pharmaceutical-analysis-21-23-september-2026/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-74th-american-society-mass-spectrometry-annual-conference-in-san-diego-may-31-june-4-2026/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-di-philogen-s-p-a-ha-approvato-il-bilancio-2025/</loc><lastmod>2026-04-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-eado-2026-23-25-april-2026/</loc><lastmod>2026-04-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-aacr-2026-in-san-diego-17-22-april-2026/</loc><lastmod>2026-04-17</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2026-2/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-an-upcoming-webinar-on-march-30-2026-at-1500-gmt-1600-cet/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2026/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio-e-il-bilancio-consolidato-al-31-dicembre-2025-price-sensitive/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements-and-the-consolidated-financial-statements-as-of-december-31st-2025-courtesy-translation-price-sensitive/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/2026-swiss-chemical-society-scs-industrial-science-award-for-samuele-cazzamalli-head-of-research-at-philochem/</loc><lastmod>2025-11-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-an-upcoming-webinar-on-november-20-2025-at-1500-gmt-1600-cet/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-financial-position-for-the-third-quarter-of-2025/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-terzo-trimestre-2025/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-to-attend-the-festival-of-biologics-2025-in-basel-on-september-30-october-2-2025/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-an-upcoming-webinar-on-september-26-2025-at-1400-gmt-1500-cet/</loc><lastmod>2025-09-26</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2025-price-sensitive/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2025-price-sensitive-courtesy-english-translation/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-european-society-of-nuclear-medicine-eanm-annual-meeting-on-october-4-8-2025/</loc><lastmod>2025-09-02</lastmod></url>
<url><loc>https://www.philogen.com/news/la-controllata-philochem-ag-annuncia-il-completamento-del-processo-autorizzativo-antitrust-e-la-conclusione-dellaccordo-di-licenza-oncoacp3-con-rayzebio-una-societa-di-bristol-myers-squibb-con-un/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-ag-announces-completion-of-antitrust-clearance-and-closing-of-the-oncoacp3-licensing-agreement-with-rayzebio-a-bristol-myers-squibb-company-with-a-potential-value-of-up-to-1-35-billion-pl/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-biopharma-and-life-sciences-private-event-in-london-uk-on-november-18-2025/</loc><lastmod>2025-08-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-management-to-hold-a-webinar-to-provide-an-update-on-nidlegy-marketing-authorization-application-in-melanoma/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-update-on-marketing-authorization-application-for-nidlegy-in-the-european-union/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-a-webinar-with-prof-dario-neri-taking-place-today-june-11-at-1100-et-1700-cet/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-ag-announces-the-licensing-of-worldwide-rights-to-oncoacp3-a-novel-radiopharmaceutical-therapeutic-and-diagnostic-agent-targeting-prostate-cancer-to-rayzebio-a-bristol-myers-squibb-compan/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://www.philogen.com/news/la-controllata-philochem-ag-ha-concesso-in-licenza-i-diritti-a-livello-mondiale-su-oncoacp3-un-nuovo-agente-terapeutico-e-diagnostico-per-il-trattamento-del-cancro-alla-prostata-a-rayzebio-societa/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://www.philogen.com/news/the-medchem-division-of-the-italian-chemical-society-sci-awarded-two-prizes-to-philochem-employees-samuele-cazzamalli-head-of-chemistry-and-sara-puglioli-research-scientist/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti-4/</loc><lastmod>2025-05-26</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2025/</loc><lastmod>2025-05-06</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-di-philogen-s-p-a-si-e-riunita-in-data-odierna-in-sede-ordinaria-e-straordinaria-3/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-society-of-nuclear-medicine-and-molecular-imaging-snmmi-annual-meeting-on-june-21-24-2025/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-aacr-2025-on-april-25-30-2025/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-pegs-boston-2025-on-may-13-16-2025/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-pubblicazione-liste-per-elezione-del-consiglio-di-amministrazione-e-altra-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2025/</loc><lastmod>2025-04-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-fy-2024-report-on-april-2-2025/</loc><lastmod>2025-04-02</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2025-2/</loc><lastmod>2025-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio-e-il-bilancio-consolidato-al-31-dicembre-2024-price-sensitive/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements-and-the-consolidated-financial-statements-as-of-december-31st-2024-courtesy-translation-price-sensitive/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-a-lecture-at-the-department-of-dermatology-university-of-tubingen-in-tubingen-germany-on-november-6-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-congress-of-the-danish-society-of-medicinal-chemistry-and-chemical-biology-dsmkb-in-copenhagen-denmark-on-january-24-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-group-retreat-of-the-group-of-prof-dr-markus-manz-in-bergun-switzerland-on-september-9-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-a-lecture-at-the-laboratory-of-molecular-biology-medical-research-council-centre-in-cambridge-uk-on-march-31-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-pegs-europe-in-barcelona-spain-on-november-7-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-a-lecture-at-astrazeneca-in-goteborg-sweden-on-may-29-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-zkb-investors-event-in-zurich-switzerland-on-december-4-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/prof-dario-neri-to-give-a-lecture-at-the-university-of-siena-italy-on-march-22-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-institute-for-chemical-immunology-conference-2024-in-leiden-the-netherlands-on-june-28-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/hilogen-to-attend-a-lecture-at-the-university-of-catania-in-catania-italy-on-january-16-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-european-association-of-dermato-oncology-eado-congress-in-paris-france-on-april-5-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-international-controlled-release-congress-in-bologna-italy-on-july-9-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-inano-at-the-university-of-aarhus-in-aarhus-denmark-on-october-31-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-a-lecture-at-the-department-of-chemistry-university-of-cambridge-in-cambridge-uk-on-march-31-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-a-lecture-at-the-gulbenkian-institute-of-molecular-medicine-gimm-in-lisbon-portugal-on-january-20-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-esmo-immunooncology-esmo-io-congress-2024-in-geneva-switzerland-on-december-13-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-world-adc-on-march-3-6-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/prof-dario-neri-to-give-a-lecture-at-the-university-of-milan-italy-on-february-19-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-viii-siena-think-tank-in-siena-italy-on-october-4-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-novo-nordisk-foundation-symposium-on-chemical-biology-from-molecules-to-medicine-in-copenhagen-denmark-on-june-7-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-zkb-investors-event-in-lausanne-switzerland-on-december-11-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-51st-adf-tagung-in-berlin-germany-on-march-14-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-12th-international-congress-on-encoded-combinatorial-libraries-in-shanghai-china-on-october-12-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-swiss-radiopharmacy-day-on-march-21-2025/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-immuno-oncology-summit-europe-in-london-uk-on-april-25-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-10th-immunotherapy-of-cancer-itoc-congress-in-munich-germany-on-march-21-2024/</loc><lastmod>2025-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2025/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-completes-patient-enrollment-of-the-phase-iii-fibrosarc-trial-in-soft-tissue-sarcoma/</loc><lastmod>2025-02-04</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-avvia-il-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-launch-of-a-share-buyback-program/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-a-new-webinar-on-december-9-2024-at-1500-gmt-1600-cet/</loc><lastmod>2024-11-19</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-financial-position-for-the-third-quarter-of-2024/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-terzo-trimestre-2024/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/sun-pharma-e-philogen-stipulano-un-accordo-di-commercializzazione-licenza-e-fornitura-in-esclusiva-per-la-commercializzazione-del-prodotto-innovativo-fibromun-a-livello-mondiale/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-a-new-webinar-on-october-1-2024-at-1500-gmt-1600-cet/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://www.philogen.com/news/sun-pharma-and-philogen-enter-into-a-global-exclusive-commercialization-license-and-supply-agreement-for-commercializing-the-specialty-product-fibromun/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-european-association-of-nuclear-medicine-eanm-annual-meeting-on-october-19-23-2024/</loc><lastmod>2024-09-27</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2024-price-sensitive/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2024-price-sensitive-courtesy-english-translation/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://www.philogen.com/news/2024-efmc-prize-for-young-medicinal-chemist-or-chemical-biologist-in-industry-for-samuele-cazzamalli-head-of-chemistry-at-philochem/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-efmc-ismc-2024-on-september-4-2024-in-rome/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-pegs2024-on-september-6-2024-in-barcelona/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-invite-you-to-a-new-webinar-on-july-10-2024-at-1400-gmt-1500-cet/</loc><lastmod>2024-07-09</lastmod></url>
<url><loc>https://www.philogen.com/news/submission-of-nidlegytm-marketing-authorization-application-validated-by-ema/</loc><lastmod>2024-07-04</lastmod></url>
<url><loc>https://www.philogen.com/news/richiesta-di-autorizzazione-allimmissione-in-commercio-per-il-prodotto-nidlegy-sottomessa-allema/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://www.philogen.com/news/nidlegy-marketing-authorization-application-submitted-to-ema/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://www.philogen.com/news/risultati-dello-studio-clinico-di-fase-iii-pivotal-di-nidlegy-nel-melanoma-da-presentare-allasco-2024/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://www.philogen.com/news/results-of-the-phase-iii-pivotal-trial-of-nidlegy-in-melanoma-to-be-presented-at-asco-2024/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti-3/</loc><lastmod>2024-05-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-to-attend-the-72nd-asms-conference-on-mass-spectrometry-and-allied-topics-in-anaheim-on-june-2-6-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-snmmi-annual-meeting-in-toronto-on-june-8-11-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-goldman-sachs-45th-annual-global-healthcare-conference-in-miami-on-june-12-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-chemical-biology-conference-at-novo-nordisk-on-june-8-9-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-asco-congress-in-chicago-on-may-30-31-june-1-3-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-to-attend-as-lecturer-to-the-summer-school-in-pharmaceutical-analysis-2024-in-rimini-on-september-18-20-2024/</loc><lastmod>2024-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-first-quarter-of-2024/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2024/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-di-philogen-s-p-a-si-e-riunita-in-data-odierna-in-sede-ordinaria-e-straordinaria-2/</loc><lastmod>2024-04-29</lastmod></url>
<url><loc>https://www.philogen.com/news/errata-corrige-parziale-rettifica-del-comunicato-stampa-del-5-aprile-2024/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-liste-per-elezione-collegio-sindacale-e-altra-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2024/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://www.philogen.com/news/approvato-il-bilancio-di-sostenibilita-2023-del-gruppo-philogen/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-delighted-to-invite-you-to-attend-a-virtual-briefing-on-april-3-2024-to-discuss-the-companys-full-year-2023-results/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2024-2/</loc><lastmod>2024-03-29</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements-and-the-consolidated-financial-statements-as-of-december-31st-2023-courtesy-translation-price-sensitive/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio-e-il-bilancio-consolidato-al-31-dicembre-2023-price-sensitive/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-29-aprile-2024/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-ag-a-company-of-the-philogen-group-announces-board-of-appeal-decision-on-philochems-patent-on-production-of-encoded-chemical-libraries/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-fornisce-un-aggiornamento-sullanalisi-ad-interim-prevista-dallo-studio-di-fase-iii-fibrosarc-che-valuta-onfekafusp-alfa-l19tnf-in-pazienti-con-sarcoma-dei-tessuti-molli-in-stato-avanzato/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-update-on-pre-planned-interim-analysis-of-the-phase-iii-fibrosarc-trial-investigating-onfekafusp-alfa-l19tnf-in-patients-with-first-line-advanced-or-metastatic-soft-tissue-sarcoma/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-italian-mid-cap-conference-organised-by-mediobanca-on-january-23-24-2024/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-esmo-tat-congress-in-paris-on-february-26-28-2024/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-immunotherapy-of-cancer-conference-itoc-in-munich-on-march-21-23-2024/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-immuno-oncology-summit-europe-in-london-on-april-23-25-2024/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-introduce-la-piattaforma-per-il-whistleblowing-direttiva-eu-2019-1937/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-receipt-of-the-good-manufacturing-practice-certificate-for-its-new-production-facility-in-rosia-siena-italy-by-competent-authorities/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-ag-a-company-of-the-philogen-group-announces-the-completion-of-central-radiolabeling-activities-for-the-therapeutic-use-of-oncofap-23/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-and-blue-earth-diagnostics-announce-first-three-patients-imaged-in-phase-1-clinical-trial-of-68ga-oncofap-68ga-oncofap-dotaga-for-diagnostic-imaging-in-solid-tumors/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://www.philogen.com/news/following-the-announcements-of-this-morning-philogen-management-is-inviting-you-to-a-webinar-on-december-5-at-1500-gmt-1600-cet/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-terzo-trimestre-2023/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-third-quarter-of-2023/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-annual-meeting-canceropole-grand-sud-ouest-in-arcachon-on-november-22-24-2023/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://www.philogen.com/news/23-ottobre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-inviting-you-to-a-webinar-on-october-18-at-1400-gmt-1500-cet-following-the-exciting-announcement-on-our-phase-iii-trial-of-nidlegy-in-locally-advanced-melanoma/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://www.philogen.com/news/nidlegy-phase-iii-pivotal-trial-meets-the-studys-primary-objective-in-patients-with-locally-advanced-fully-resectable-melanoma-price-sensitive/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://www.philogen.com/news/16-ottobre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://www.philogen.com/news/nidlegy-ha-raggiunto-positivamente-lobiettivo-primario-dello-studio-di-fase-iii-pivotal-in-pazienti-con-melanoma-localmente-avanzato-completamente-resecabile-price-sensitive/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://www.philogen.com/news/09-ottobre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://www.philogen.com/news/02-ottobre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-12th-annual-cell-culture-bioprocessing-congress-in-london-on-november-07-08-2023-2/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-pegs-europe-2023-congress-in-lisbon-on-november-14-16-2023/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-kindly-invites-you-to-attend-a-virtual-briefing-for-analysts-on-2-october-2023-to-discuss-companys-half-year-2023-results/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-esmo-congress-in-madrid-on-october-20-24-2023/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-festival-of-biologics-2023-congress-in-basel-on-october-10-12-2023/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-world-adc-2023-congress-in-san-diego-on-october-16-19-2023/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-efmc-international-symposium-on-chemical-biology-2023-congress-in-basel-on-november-16-18-2023/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2023-price-sensitive-courtesy-english-translation/</loc><lastmod>2023-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2023-price-sensitive/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/25-settembre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://www.philogen.com/news/fighting-cancer-the-italian-chemical-society-award-to-dario-neri-ceo-of-philogen/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://www.philogen.com/news/18-settembre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://www.philogen.com/news/11-agosto-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-09-11</lastmod></url>
<url><loc>https://www.philogen.com/news/04-settembre-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-09-04</lastmod></url>
<url><loc>https://www.philogen.com/news/28-agosto-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-drug-conjugates-in-directed-therapy-in-darmstadt-on-august-23-25-2023/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://www.philogen.com/news/21-agosto-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://www.philogen.com/news/14-agosto-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://www.philogen.com/news/07-agosto-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://www.philogen.com/news/31-luglio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://www.philogen.com/news/24-luglio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://www.philogen.com/news/17-luglio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://www.philogen.com/news/10-luglio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-new-publication-in-nature-chemistry/</loc><lastmod>2023-07-04</lastmod></url>
<url><loc>https://www.philogen.com/news/03-luglio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-07-03</lastmod></url>
<url><loc>https://www.philogen.com/news/we-are-thrilled-to-announce-a-service-and-supply-agreement-with-ibsa-for-the-gmp-production-of-a-therapeutic-protein/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://www.philogen.com/news/26-giugno-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://www.philogen.com/news/19-giugno-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://www.philogen.com/news/12-giugno-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://www.philogen.com/news/05-giugno-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-kindly-invites-you-to-attend-a-virtual-briefing-for-analysts-on-5-june-2023-to-discuss-the-companys-latest-updates/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-clinical-trial-collaboration-with-msd/</loc><lastmod>2023-06-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-antibody-engineering-therapeutics-europe-2023-in-amsterdam-on-june-6-8-2023/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://www.philogen.com/news/sun-pharma-and-philogen-enter-into-an-exclusive-distribution-license-and-supply-agreement-for-commercializing-specialty-product-nidlegy-in-europe-australia-and-new-zealand-price-sensitiv/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://www.philogen.com/news/sun-pharma-e-philogen-stipulano-un-accordo-di-commercializzazione-licenza-e-fornitura-in-esclusiva-per-il-prodotto-innovativo-nidlegy-in-europa-australia-e-nuova-zelanda-price-sensitive/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://www.philogen.com/news/29-maggio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-05-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-publishes-new-data-on-a-fibromun-based-treatment-combination-in-science-translational-medicine-in-collaboration-with-the-university-hospital-zurich/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dell-assemblea-degli-azionisti-2023/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/22-maggio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-nomina-mediobanca-banca-di-credito-finanziario-s-p-a-quale-intermediario-incaricato-dellesecuzione-del-programma-di-acquisto-di-azioni-proprie-2/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2023/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-first-quarter-of-2023/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://www.philogen.com/news/02-maggio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-di-philogen-s-p-a-si-e-riunita-in-data-odierna-in-sede-ordinaria-e-straordinaria/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://www.philogen.com/news/24-aprile-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://www.philogen.com/news/17-aprile-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://www.philogen.com/news/11-aprile-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-28-aprile-2023/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://www.philogen.com/news/03-aprile-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-of-a-new-study-in-collaboration-with-google-focused-on-machine-learning-models-applied-to-dna-encoded-chemical-library-technology/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio-e-il-bilancio-consolidato-al-31-dicembre-2022-price-sensitive/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-dellavviso-di-convocazione-dellassemblea-degli-azionisti-e-delle-relazioni-illustrative-dei-punti-allordine-del-giorno/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements-and-the-consolidated-financial-statements-as-of-december-31st-2022-courtesy-translation-price-sensitive/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/27-marzo-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/20-marzo-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-03-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-immuno-oncology-summit-europe-2023-in-london-on-june-20-22-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-aacr-annual-meeting-in-orlando-on-april-14-18-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-stifel-european-healthcare-summit-in-bordeaux-on-june-28-30-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-19th-pegsboston-in-boston-on-may-15-19-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-mid-small-london-2023-conference-on-april-20-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-74th-mosbacher-kolloquium-in-mosbach-baden-on-march-23-25-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-19th-eado-congress-on-april-20-22-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-to-attend-the-71st-american-society-for-mass-spectrometry-conference-on-june-4-8-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-lund-spring-symposium-in-lund-on-may-22-24-2023/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/13-marzo-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-03-13</lastmod></url>
<url><loc>https://www.philogen.com/news/06-marzo-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-03-06</lastmod></url>
<url><loc>https://www.philogen.com/news/27-febbraio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://www.philogen.com/news/20-febbraio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://www.philogen.com/news/13-febbraio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://www.philogen.com/news/cell-press-highlights-the-work-of-philochems-industrial-ph-d-student/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://www.philogen.com/news/06-febbraio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-publishes-a-new-study-in-pharmaceutics/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://www.philogen.com/news/30-gennaio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-european-bispecific-and-multispecific-antibody-congress-in-amsterdam-on-the-22nd-and-23rd-of-february-2023/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/23-gennaio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-7th-annual-next-gen-immuno-oncology-conference-congress-in-london-on-the-9th-and-10th-of-march-2023/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/16-gennaio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-01-16</lastmod></url>
<url><loc>https://www.philogen.com/news/09-gennaio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://www.philogen.com/news/02-gennaio-2023-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2023-01-02</lastmod></url>
<url><loc>https://www.philogen.com/news/27-dicembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-12-27</lastmod></url>
<url><loc>https://www.philogen.com/news/19-dicembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://www.philogen.com/news/12-dicembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-mediobanca-5th-midcap-conference-on-january-18-2023-in-milan/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-13th-world-adc-conference-in-london-on-the-13th-and-14th-of-march-2023/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-jp-morgan-on-january-9-12-2023-in-san-francisco/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://www.philogen.com/news/05-dicembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-melanoma-bridge-in-naples-1-3-december-2022/</loc><lastmod>2022-12-03</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-antibody-engineering-therapeutics-on-december-4-8-2022-in-san-diego/</loc><lastmod>2022-12-03</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-corporate-update-4/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://www.philogen.com/news/28-novembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://www.philogen.com/news/21-novembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-11-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-in-protein-science-on-the-selection-and-structural-characterization-of-a-novel-pd-1-blocking-antibody/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://www.philogen.com/news/14-novembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-the-publication-of-a-new-study-in-the-european-journal-of-nuclear-medicine-and-molecular-imaging/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-terzo-trimestre-2022/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-third-quarter-of-2022/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://www.philogen.com/news/07-novembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-in-chem-cell-press-on-novel-affinity-matured-oncofap-ligands/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-upcoming-calendar-of-corporate-events-third-quarter-financial-results-and-corporate-update/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://www.philogen.com/news/31-ottobre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://www.philogen.com/news/24-ottobre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-publishes-a-new-study-on-oncofap-in-clinical-cancer-research/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://www.philogen.com/news/17-ottobre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://www.philogen.com/news/10-ottobre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://www.philogen.com/news/03-ottobre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2022-price-sensitive/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2022-price-sensitive-courtesy-english-translation/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogens-management-team-will-hold-a-webinar-on-29-september-2022-at-1600-cest/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/26-settembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-09-26</lastmod></url>
<url><loc>https://www.philogen.com/news/19-settembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-09-19</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-of-il12-7np2-an-interleukin-12-fusion-protein-against-fibroblast-activation-protein-in-journal-for-immunotherapy-of-cancer/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://www.philogen.com/news/12-settembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-present-at-upcoming-conferences/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://www.philogen.com/news/05-settembre-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-09-05</lastmod></url>
<url><loc>https://www.philogen.com/news/29-agosto-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://www.philogen.com/news/22-agosto-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://www.philogen.com/news/16-agosto-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://www.philogen.com/news/08-agosto-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-08-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-enrolment-of-214-patients-in-the-nidlegy-phase-iii-european-clinical-trial-for-the-treatment-of-locally-advanced-melanoma/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://www.philogen.com/news/25-luglio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie-2/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://www.philogen.com/news/18-luglio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://www.philogen.com/news/11-luglio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-07-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-peptide-therapeutic-forum-2022-on-august-25-26-2022/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-international-mass-spectrometry-congress-2022-in-maastricht-august-27th-september-2nd-2022/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://www.philogen.com/news/04-luglio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-07-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-society-for-immunotherapy-of-cancers-37th-annual-meeting-2022-in-boston-8-12-november-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-eano-congress-in-vienna-austria-15-18-september-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-10th-international-symposium-on-dna-encoded-chemical-libraries-in-boston-3-4-november-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-13th-world-adc-san-diego-2022-san-diego-usa-6-9-september-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-3rd-annual-cytokine-based-drug-development-summit-boston-july-26-29-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-bio-europe-in-leipzig-on-october-24-26-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-emerging-technologies-and-methodologies-in-small-molecule-drug-discovery-synthesis-symposium-in-toledo-27-29-september-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-festival-of-biologics-in-basel-2-4-november-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-the-12th-european-post-chicago-melanoma-skin-cancer-meeting-30-1-july/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-european-society-for-medical-oncology-paris-9-13-september-2022/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/27-giugno-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-corporate-update-3/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://www.philogen.com/news/20-giugno-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-rd-update-webinar-on-june-23-2022/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://www.philogen.com/news/13-giugno-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://www.philogen.com/news/06-giugno-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://www.philogen.com/news/30-maggio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-05-30</lastmod></url>
<url><loc>https://www.philogen.com/news/23-maggio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-05-23</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti-2/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://www.philogen.com/news/16-maggio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-first-quarter-of-2022/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2022/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/09-maggio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-present-at-ubs-global-healthcare-conference/</loc><lastmod>2022-05-05</lastmod></url>
<url><loc>https://www.philogen.com/news/02-maggio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-ha-approvato-il-bilancio-di-esercizio-2021-e-la-politica-di-remunerazione-ha-nominato-il-nuovo-consiglio-di-amministrazione-e-il-relativo-presidente-per-il-trienn/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://www.philogen.com/news/26-aprile-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://www.philogen.com/news/19-aprile-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://www.philogen.com/news/11-aprile-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-documentazione-relativa-allassemblea-degli-azionisti-convocata-per-il-27-aprile-2022/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-reports-full-year-2021-results-and-provides-corporate-update/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-fy-2021-virtual-briefing/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://www.philogen.com/news/28-marzo-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements-and-the-consolidated-financial-statements-as-of-december-31st-2021courtesy-english-translation/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio-e-il-bilancio-consolidato-al-31-dicembre-2021/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-delle-relazioni-illustrative-sul-bilancio-di-esercizio-al-31-dicembre-2021-e-sulla-relazione-sulla-politica-in-materia-di-remunerazione-e-sui-compensi-corrisposti/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-and-bracco-imaging-announce-a-collaboration-on-the-development-of-a-small-molecule-for-diagnostic-or-medical-imaging-applications/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-e-bracco-imaging-annunciano-una-collaborazione-per-lo-sviluppo-di-una-piccola-molecola-per-applicazioni-di-imaging-diagnostico/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://www.philogen.com/news/21-marzo-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-seminar-on-drug-sciences-organized-by-the-university-of-basel-march-23-2022/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-workshop-il-sistema-ricerca-industria-in-italia-at-accademia-dei-lincei-rome-italy-on-march-18-2022/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-12th-annual-world-adc-2022-on-march-29-31/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/notice-of-full-year-2021-results/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-2022-ubs-global-healthcare-conference-on-may-23-25-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-chemical-biology-and-drug-discovery-research-seminars-at-imperial-college-london-on-may-10-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-tides-europe-2022-in-vienna-austria-16-18-november/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-give-a-lecture-at-the-institute-cancer-center-amsterdam-on-april-5-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-immune-oncology-summit-in-london-on-may-24-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-join-the-department-of-radiology-at-cambridge-university-uk-for-a-lecture-on-june-22-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-tides-2022-on-may-9-12-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-aacr-annual-meeting-on-april-8-13-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-world-federation-of-neuro-oncology-societies-wfnos-2022-virtual-2022-annual-meeting-on-march-24-27-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-jefferies-healthcare-conference-in-london-november-15-17-2022/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://www.philogen.com/news/14-marzo-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-03-14</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-relazione-illustrativa-sulla-nomina-del-consiglio-di-amministrazione-e-dellavviso-di-convocazione-dellassemblea-dei-soci-del-27-aprile-2022/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://www.philogen.com/news/07-marzo-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://www.philogen.com/news/28-febbraio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://www.philogen.com/news/21-febbraio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-receives-authorisation-to-initiate-new-study-in-france-to-evaluate-nidlegy-in-several-non-melanoma-skin-cancers/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://www.philogen.com/news/14-febbraio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://www.philogen.com/news/07-febbraio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-02-07</lastmod></url>
<url><loc>https://www.philogen.com/news/31-gennaio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://www.philogen.com/news/24-gennaio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-01-24</lastmod></url>
<url><loc>https://www.philogen.com/news/17-gennaio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://www.philogen.com/news/10-gennaio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-of-pet-clinical-data-with-proprietary-ultra-high-affinity-fap-targeting-small-molecule-ligand-oncofap/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-italian-mid-cap-conference-organised-by-mediobanca-on-january-19-20-2022/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-italian-top-picks-event-organised-by-stifel-on-january-17-2022/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://www.philogen.com/news/3-gennaio-2022-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://www.philogen.com/news/27-dicembre-2021-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2021-12-27</lastmod></url>
<url><loc>https://www.philogen.com/news/20-dicembre-2021-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://www.philogen.com/news/13-dicembre-2021-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2021-12-13</lastmod></url>
<url><loc>https://www.philogen.com/news/06-dicembre-2021-aggiornamento-sul-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti-price-sensitive/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-nomina-mediobanca-banca-di-credito-finanziario-s-p-a-quale-intermediario-incaricato-dellesecuzione-del-programma-di-acquisto-di-azioni-proprie/</loc><lastmod>2021-11-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-new-collaboration-with-janssen-to-discover-small-molecule-therapeutics/</loc><lastmod>2021-11-24</lastmod></url>
<url><loc>https://www.philogen.com/news/lassemblea-degli-azionisti-autorizza-lacquisto-e-la-disposizione-di-azioni-proprie-ed-il-consiglio-di-amministrazione-approva-lavvio-del-programma-price-sensitive/</loc><lastmod>2021-11-24</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicazione-ai-sensi-dellart-85-bis-comma-4-bis-del-regolamento-emittenti/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-q3-2021-virtual-briefing/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-corporate-update-2/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-as-30-september-2021-price-sensitive-courtesy-english-translation/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-terzo-trimestre-2021-price-sensitive/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-together-with-the-university-of-zurich-to-participate-at-the-26th-annual-meeting-education-of-the-society-for-neuro-oncology-on-november-18-21-2021/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-connective-tissue-oncology-society-ctos-virtual-2021-annual-meeting-on-november-10-13-2021/</loc><lastmod>2021-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-festival-of-biologics-basel-on-november-10-2021/</loc><lastmod>2021-11-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-2021-virtual-stifel-healthcare-conference-on-november-15-17-2021/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-cytokine-based-cancer-immunotherapies-summit-on-november-30-december-2-2021/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-antibody-engineering-therapeutics-on-december-12-16-2021/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-its-q3-2021-results-on-thursday-11th-november-2021/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://www.philogen.com/news/avviso-di-pubblicazione-della-relazione-illustrativa-sulla-proposta-di-autorizzazione-allacquisto-e-alla-disposizione-di-azioni-proprie/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicato-relativo-allapprovazione-del-cda-sulla-proposta-di-autorizzazione-allacquisto-e-alla-disposizione-di-azioni-proprie-price-sensitive/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-1h2021-virtual-briefing/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-philochem-patent-upheld/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-rd-program-update-for-dekavil/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-bio-europe-digital-2021-on-october-25-28-2021/</loc><lastmod>2021-10-05</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-provides-corporate-update/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-half-yearly-financial-report-at-30-june-2021-price-sensitive-courtesy-english-translation/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-relazione-finanziaria-semestrale-al-30-giugno-2021-price-sensitive/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-its-maiden-half-year-2021-results-on-thursday-28th-september-2021/</loc><lastmod>2021-09-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-ceo-cso-dario-neri-to-give-two-lectures-on-september-1st/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-interx-and-scripps-research-announce-a-research-collaboration-in-the-field-of-dna-encoded-chemistry-and-tumor-targeting/</loc><lastmod>2021-08-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-european-society-for-medical-oncology-2021-conference-on-september-16-19-2021/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-kbc-life-sciences-conference-on-september-7-9-2021/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-goldman-sachs-eleventh-annual-biotech-symposium-on-september-7/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-oppenheimer-fall-healthcare-life-sciences-med-tech-summit-on-september-23-2021/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-morgan-stanley-virtual-19th-annual-global-healthcare-conference-on-september-9-15/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-rd-program-update/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://www.philogen.com/news/deposito-del-verbale-dellassemblea-degli-azionisti/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-attend-the-11th-post-chicago-meeting-on-melanoma-skin-cancer-on-july-8-9-2021/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-present-at-the-5th-annual-eu-investor-tour-on-july-13-14-2021/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-organise-a-non-deal-roadshow-with-investors-on-july-5-7-2021/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-participate-at-the-bio-digital-2021-on-june-14-18-2021/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-to-present-at-the-ceo-roundtable-zoom-session-organised-by-goldman-sachs-in-june-2021/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicato-deliberazioni-assemblea-press-release-shareholders-meeting-decisions-price-sensitive/</loc><lastmod>2021-05-31</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-first-quarter-2021-results/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicazione-ex-art-85-bis-comma-4-bis-regolamento-emittenti/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-annuncia-i-risultati-del-primo-trimestre-2021/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-first-quarter-2021-results-and-provides-update-on-pipeline-progress/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-will-announce-its-maiden-first-quarter-2021-results-on-wednesday-12th-may-2021/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-la-posizione-finanziaria-netta-relativa-al-primo-trimestre-2021/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-net-financial-position-for-the-first-quarter-of-2021/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-will-be-attending-the-pegs-boston-virtual-summit-from-may-11th-to-13th-2021/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-of-best-in-class-fap-targeting-small-molecule-ligand-oncofap-in-pnas/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://www.philogen.com/news/il-consiglio-di-amministrazione-approva-il-progetto-di-bilancio-di-esercizio/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://www.philogen.com/news/the-board-of-directors-approves-the-draft-financial-statements/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicazione-dellammontare-complessivo-dei-diritti-di-voto/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://www.philogen.com/news/comunicazione-variazione-capitale-sociale-philogen-s-p-a/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-its-intention-to-float-on-the-mercato-telematico-azionario-organised-and-managed-by-borsa-italiana-s-p-a/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-its-intention-to-float-on-the-mercato-telematico-azionario-organised-and-managed-by-borsa-italiana-s-p-a-2/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-the-completion-of-a-second-interim-analysis-of-its-phase-iii-clinical-program-with-nidlegytm-for-the-treatment-of-melanoma/</loc><lastmod>2021-01-13</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-will-be-attending-the-pegs-europe-virtual-conference-from-november-9-to-12-2020/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-will-be-attending-the-next-generation-protein-therapeutics-bioconjugates-summit/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-publication-of-malignant-brain-tumor-study-results-in-science-translational-medicine/</loc><lastmod>2020-10-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-will-be-attending-the-world-adc-digital-conference/</loc><lastmod>2020-09-15</lastmod></url>
<url><loc>https://www.philogen.com/news/our-co-founder-and-chief-scientific-officer-prof-dario-neri-will-join-philogen-in-a-full-time-capacity/</loc><lastmod>2020-08-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-a-publication/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-received-clinical-trial-authorisation-with-nidlegytm-in-nonmelanoma-skin-cancer/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-received-combination-pack-approval-for-nidlegytm/</loc><lastmod>2020-06-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-option-exercise-by-janssen/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://www.philogen.com/news/keynote-lecture-of-prof-dr-dario-neri/</loc><lastmod>2019-10-14</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-capital-increase/</loc><lastmod>2019-05-13</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-collaboration-with-novartis/</loc><lastmod>2019-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-collaboration-with-celgene/</loc><lastmod>2019-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-drug-discovery-collaboration-with-johnson-johnson-innovation/</loc><lastmod>2019-01-23</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-receives-orphan-drug-designation-for-the-treatment-of-soft-tissue-sarcoma/</loc><lastmod>2019-01-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-receives-orphan-drug-designation-for-the-treatment-of-melanoma/</loc><lastmod>2018-07-18</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-exercise-of-options-within-the-license-agreement-with-abbvie-in-the-field-of-immuno-inflammation/</loc><lastmod>2018-02-28</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-and-the-scripps-research-institute-announce-research-collaboration-in-the-field-of-dna-encoded-chemistry/</loc><lastmod>2018-01-08</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-the-authorisation-of-a-clinical-trial-with-phc-102-for-the-imaging-of-renal-cell-carcinoma/</loc><lastmod>2017-10-19</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-authorization-from-fda-of-a-pivotal-registration-trial-in-usa-for-the-treatment-of-resectable-melanoma/</loc><lastmod>2017-10-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announces-research-collaboration-with-servier-in-the-field-of-dna-encoded-chemistry/</loc><lastmod>2017-08-25</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-enters-into-multi-target-research-agreement/</loc><lastmod>2017-07-20</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-to-the-focis-annual-meeting-2017-june-14-17-2017-chicago-usa/</loc><lastmod>2017-05-25</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-to-the-5th-heidelberg-forum-for-young-life-scientists-june-8-9-2017-heidelberg-germany/</loc><lastmod>2017-05-24</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-the-publication/</loc><lastmod>2017-05-10</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-to-the-chi-immuno-oncology-summit-europe-march-20-24-2017-london-uk/</loc><lastmod>2017-02-14</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-to-the-7th-annual-world-adc-berlin-meeting-february-20-22-2017-berlin-germany/</loc><lastmod>2017-02-14</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-to-the-pegs-boston-the-essential-protein-engineering-summit-2017-may-1-5-2017-boston-usa/</loc><lastmod>2017-02-10</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announces-participation-in-the-antibody-engineering-therapeutics-meeting-11-15-december-2016-san-diego-ca/</loc><lastmod>2016-12-13</lastmod></url>
<url><loc>https://www.philogen.com/news/3rd-shanghaitech-siais-bioforum/</loc><lastmod>2016-11-07</lastmod></url>
<url><loc>https://www.philogen.com/news/world-immunotherapy-congress-2016/</loc><lastmod>2016-11-01</lastmod></url>
<url><loc>https://www.philogen.com/news/pegs-europe-protein-antibody-engineering-summit/</loc><lastmod>2016-10-31</lastmod></url>
<url><loc>https://www.philogen.com/news/the-european-commission-ec-has-granted-orphan-drug-designation-to-l19tnf/</loc><lastmod>2016-10-28</lastmod></url>
<url><loc>https://www.philogen.com/news/xxiv-efmc-international-symposium-on-medicinal-chemistry/</loc><lastmod>2016-08-11</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announced-that-they-have-entered-into-a-collaboration-option-and-license-agreement-with-janssen-biotech/</loc><lastmod>2016-08-03</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-spa-announced-the-successful-gmp-production-of-phc-102-for-the-imaging-of-renal-cell-carcinoma/</loc><lastmod>2016-07-25</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announce-expanded-research-and-development-agreement-with-abbvie/</loc><lastmod>2016-02-15</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announced-the-launch-of-a-pivotal-trial-in-patients-with-stage-iiib-c-melanoma/</loc><lastmod>2016-01-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-s-p-a-announced-that-pfizer-inc-nyse-pfe-has-exercised-options-granted-under-the-agreement-established-in-december-2014/</loc><lastmod>2016-01-21</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-awarded-a-research-grant-from-regione-toscana/</loc><lastmod>2015-12-23</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-the-co-founder-and-chairman-of-the-scientific-advisory-board-presented-at-the-11th-annual-european-antibody-congress-in-basel-switzerland-9th-11th-november/</loc><lastmod>2015-11-09</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-the-co-founder-and-chairman-of-the-scientific-advisory-board-of-philogen-will-deliver-the-keynote-speech-at-the-first-boston-symposium-of-encoded-library-platforms-in-boston/</loc><lastmod>2015-11-06</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-is-pleased-to-announce-that-it-has-signed-a-collaborative-agreement-with-boehringer-ingelheim/</loc><lastmod>2015-10-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-data-from-phase-ib-clinical-trial-of-dekavil-in-rheumatoid-arthritis/</loc><lastmod>2015-09-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-attended-bio-in-philadelphia-pa-usa-15th-19th-june-2015/</loc><lastmod>2015-06-12</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-presented-dekavil-f8-il10/</loc><lastmod>2015-06-06</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-and-his-lab-at-the-eth-zurich-are-the-recipient-of-an-erc-advanced-grant/</loc><lastmod>2015-06-01</lastmod></url>
<url><loc>https://www.philogen.com/news/giulio-casi-presented-targeting-disease-with-armed-antibodies-and-small-molecule-drug-conjugates/</loc><lastmod>2015-05-22</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-presented-arming-tumor-targeting-antibodies-with-cytokine-payloads-emerging-clinical-results-2/</loc><lastmod>2015-05-01</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-presented-arming-tumor-targeting-antibodies-with-cytokine-payloads-emerging-clinical-results/</loc><lastmod>2015-04-19</lastmod></url>
<url><loc>https://www.philogen.com/news/mattia-matasci-presented-targeting-disease-with-armed-antibodies-small-molecule-drug-conjugates/</loc><lastmod>2015-04-13</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-presented-antibody-cytokine-fusion-proteins-from-the-bench-to-the-clinic/</loc><lastmod>2015-03-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-was-present-at-bio-europe-spring-conference-paris-france-9th-11th-march/</loc><lastmod>2015-03-09</lastmod></url>
<url><loc>https://www.philogen.com/news/philochem-announced-the-publication-in-the-prestigious-journal-nature-chemistry/</loc><lastmod>2015-03-03</lastmod></url>
<url><loc>https://www.philogen.com/news/giulio-casi-presented-arming-disease-targeting-ligands-with-cytokines-and-cytotoxic-drugs/</loc><lastmod>2015-02-24</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-presented-immunocytokines-for-the-therapy-of-cancer-and-of-chronic-inflammation/</loc><lastmod>2015-01-27</lastmod></url>
<url><loc>https://www.philogen.com/news/philogen-announced-option-and-license-agreement-with-pfizer-inc/</loc><lastmod>2014-12-22</lastmod></url>
<url><loc>https://www.philogen.com/news/dario-neri-presented-immunocytokines-for-the-therapy-of-cancer-and-of-chronic-inflammation-at-antibody-engineering-and-therapeutics-conference/</loc><lastmod>2014-12-07</lastmod></url>
<url><loc>https://www.philogen.com/careers/intern-financial-office/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://www.philogen.com/careers/graduates-in-biology-biotechnology-chemistry/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://www.philogen.com/careers/manutentore-elettromeccanico-junior/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://www.philogen.com/careers/deputy-chief-medical-officer/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://www.philogen.com/careers/archivist-protected-category-law-68-99/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://www.philogen.com/careers/clinical-research-associate/</loc><lastmod>2026-10-28</lastmod></url>
</urlset>
